European Market Report for Insulin Syringes 2016 - MedCore

  • ID: 3846014
  • Report
  • Region: Europe
  • 61 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
The insulin syringe market is a fast declining segment. Although the product was once a popular method of injecting insulin, patients have transitioned towards new technologies such as insulin pens and pumps, thereby cannibalizing the insulin syringe segment. Safety insulin syringes are now mainly used in professional healthcare settings, such as hospitals, whereas conventional syringes are no longer used as frequently. Syringe use is still relatively high in Italy due to historical trends, but it is expected that patients will continue to switch to insulin pens and pumps for convenience.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
Table Of Contents I
List Of Figures Iv
List Of Charts V
Executive Summary
European Market For Diabetes Monitoring, Treatment And Drug Delivery
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
Country Profiles
3.1 Introduction
3.1.1 Population
3.1.2 Gdp Per Capita
3.1.3 Units
3.2 Germany
3.3 France
3.4 United Kingdom
3.5 Italy
3.6 Spain
3.7 Benelux
3.8 Scandinavia
3.9 Austria
3.10 Switzerland
3.11 Portugal
Insulin Syringe Market
4.1 Introduction
4.2 Market Analysis And Forecast
4.3 Drivers And Limiters
4.3.1 Market Drivers
4.3.2 Market Limiters
4.4 Competitive Market Share Analysis
Abbreviations

Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022
Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022
Chart 3 1: Country Profile, Germany, 2015
Chart 3 2: Country Profile, France, 2015
Chart 3 3: Country Profile, United Kingdom, 2015
Chart 3 4: Country Profile, Italy, 2015
Chart 3 5: Country Profile, Spain, 2015
Chart 3 6: Country Profile, Benelux, 2015
Chart 3 7: Country Profile, Scandinavia, 2015
Chart 3 8: Country Profile, Austria, 2015
Chart 3 9: Country Profile, Switzerland, 2015
Chart 3 10: Country Profile, Portugal, 2015
Chart 4 1: Total Insulin Syringe Market, Europe, 2012 – 2022
Chart 4 2: Leading Competitors, Insulin Syringe Market, Europe, 2015

Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2015
Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016
Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 4 1: Total Insulin Syringe Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 2: Units Sold (Millions) by Country, Total Insulin Syringe Market, Europe, 2012-2022
Figure 4 3: Average Sales Price by Country, Total Insulin Syringe Market, Europe, 2012-2022 (€)
Figure 4 4: Average Sales Price by Country, Total Insulin Syringe Market, Europe, 2012-2022 (US$)
Figure 4 5: Total Insulin Syringe Market by Country, Europe, 2012-2022 (€M)
Figure 4 6: Total Insulin Syringe Market by Country, Europe, 2012-2022 (US$M)
Figure 4 7: Drivers and Limiters, Insulin Syringe Market, Europe, 2015
Figure 4 8: Leading Competitors, Insulin Syringe Market, Europe, 2015
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, resulting in a fast decline in insulin syringe use across Europe.

Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.
Note: Product cover images may vary from those shown
5 of 5
Novo Nordisk
Sanofi
Roche
Johnson & Johnson
Eli Lilly
Abbott
Ascensia
Becton Dickinson
Medtronic
Menarini
DexCom
Ypsomed
Insulet
Artsana
B. Braun
Terumo
Others include: Abbott, AgaMatrix, Artsana, Apollo, BBI Healthcare, B. Braun, Berger, Beurer, Boehringer Ingelheim, Cellnovo, Codan, Comfort Point, Dario Health, Elektronika, Entra Health Systems, GlucoRx, GlucoZen, Infopia, Medtronic, MED TRUST, Medisana, Menarini, Merck Serono, MSP bodmann, Neon Diagnostics, NordicInfu Care, Novalab Ibérica, Novico, Owen Mumford, Pentaferte, Roche, Sanofi, SD BIOSENSOR, SFM Medical, Smiths Medical, Spirit Healthcare, Sooil, Trividia Health, Ypsomed, etc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll